Top Markets
#1 Black Phoenix Black Phoenix +820.83%
#2 Tutorial Tutorial +25.27%
#3 Beam Beam +25.04%
#4 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.53%
#5 MiL.k Alliance MiL.k Alliance +20.24%
#6 SAFEcoin SAFEcoin +18.55%
#7 Bless Bless +18.33%
#8 Wrapped STX (Velar) Wrapped STX (Velar) +15.85%
#9 THORChain THORChain +15.63%
#10 Magma Finance Magma Finance +15.39%
Coin of the day
Black Phoenix Black Phoenix
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Lin BioScience, Inc. Lin BioScience, Inc.

Lin BioScience, Inc.

6696
Rangering i aksjer #5731
Lin BioScience, Inc. is an innovative biopharmaceutical company focused on... Lin BioScience, Inc. is an innovative biopharmaceutical company focused on developing novel therapies across oncology, ophthalmology, and metabolic diseases. Its robust pipeline includes LBS-008, an orally administered treatment currently in Phase 3 clinical trials for adolescent Stargardt disease (STGD1) and Phase 2/3 trials for dry age-related macular degeneration (Dry AMD), both aimed at evaluating its safety and effectiveness. Other key candidates are LBS-007, a natural non-ATP CDC7 inhibitor designed to combat various cancers; LBS-002, an anti-tubulin compound targeting primary and metastatic brain tumors; and LBS-009, an oral medication for non-alcoholic fatty liver disease and Type 2 diabetes. The company is headquartered in Taipei, Taiwan.
Aksjekurs
$29.86
Sist synkronisert: 2026-08-19
Markedsverdi
$2.48B
Endring (1 dag)
4.92%
Endring (1 år)
502.82%
Land
TW
Handel Lin BioScience, Inc. (6696)

Kategori

Healthcare
Antall utestående aksjer for Lin BioScience, Inc. (6696)
Antall utestående aksjer per August 2026: 0
Ifølge Lin BioScience, Inc. sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 0. Ved slutten av August 2026 hadde selskapet 0 utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Lin BioScience, Inc. (6696) fra 2026 til 2026
Utestående aksjer ved utgangen av hvert år
År Utestående aksjer Endre
Ikke nok data for de angitte datoene.
Utestående aksjer for lignende selskaper eller konkurrenter
Selskap Utestående aksjer Forskjell Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 478.91M -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 396.00M -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH